EUVIMEDEUVIMED entdecken
Open Access

The role of cellular senescence in profibrillatory atrial remodelling associated with cardiac pathology

Mozhdeh Mehdizadeh, Patrice Naud, Issam H Abu-Taha, Roddy Hiram, Feng Xiong, Jiening Xiao, Arnela Saljic iD, Markus Kamler, Nhung Vuong-Robillard, Eric Thorin iD, Gerardo Ferbeyre iD, Jean-Claude Tardif iD und 4 weitere

Cardiovascular Research · 30.04.2024 · 120 (5) · 506-518

DOI: 10.1093/cvr/cvae003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 05.01.2024. Verfasst von Mozhdeh Mehdizadeh und 15 weiteren Autor:innen. Beteiligte Einrichtung: Research Center, Montreal Heart Institute, Université de Montréal, 5000 Belanger Street, Montreal, Quebec H1T 1C8, Canada. Hauptthemen laut MEDLINE: Cellular Senescence, Atrial Fibrillation, Atrial Remodeling, Fibrosis. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CIHR, NHLBI NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Cellular senescence is a stress-related or aging response believed to contribute to many cardiac conditions; however, its role in atrial fibrillation (AF) is unknown. Age is the single most important determinant of the risk of AF. The present study was designed to (i) evaluate AF susceptibility and senescence marker expression in rat models of aging and myocardial infarction (MI), (ii) study the effect of reducing senescent-cell burden with senolytic therapy on the atrial substrate in MI rats, and (iii) assess senescence markers in human atrial tissue as a function of age and the presence of AF. Methods and results AF susceptibility was studied with programmed electrical stimulation. Gene and protein expression was evaluated by immunoblot or immunofluorescence (protein) and digital polymerase chain reaction (PCR) or reverse transcriptase quantitative PCR (messenger RNA). A previously validated senolytic combination, dasatinib and quercetin, (D+Q; or corresponding vehicle) was administered from the time of sham or MI surgery through 28 days later. Experiments were performed blinded to treatment assignment. Burst pacing-induced AF was seen in 100% of aged (18-month old) rats, 87.5% of young MI rats, and 10% of young control (3-month old) rats (P ≤ 0.001 vs. each). Conduction velocity was slower in aged [both left atrium (LA) and right atrium (RA)] and young MI (LA) rats vs. young control rats (P ≤ 0.001 vs. each). Atrial fibrosis was greater in aged (LA and RA) and young MI (LA) vs. young control rats (P < 0.05 for each). Senolytic therapy reduced AF inducibility in MI rats (from 8/9 rats, 89% in MI vehicle, to 0/9 rats, 0% in MI D + Q, P < 0.001) and attenuated LA fibrosis. Double staining suggested that D + Q acts by clearing senescent myofibroblasts and endothelial cells. In human atria, senescence markers were upregulated in older (≥70 years) and long-standing AF patients vs. individuals ≤60 and sinus rhythm controls, respectively.

Conclusion

Our results point to a potentially significant role of cellular senescence in AF pathophysiology. Modulating cell senescence might provide a basis for novel therapeutic approaches to AF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cellular SenescenceAtrial FibrillationAtrial RemodelingFibrosisHeart AtriaDisease Models, AnimalMyocardial InfarctionAnimalsHumansMaleQuercetinSenotherapeuticsAge FactorsFemaleAgedMiddle AgedCardiac Pacing, Artificial

Stichwörter der Autor:innen

AF susceptibilityCellular senescenceFibrosisMyocardial infarctionSenolytic drugs

Substanzen

QuercetinSenotherapeutics

Autor:innen und Institutionen

  • Research Center, Montreal Heart Institute, Université de Montréal, 5000 Belanger Street, Montreal, Quebec H1T 1C8, Canada.
  • Department of Pharmacology and Therapeutics, McGill University, 3655 Promenade Sir-William-Osler, Montreal, Quebec H3G 1Y6, Canada.
  • Department of Medicine, Université de Montréal, Pavillon Roger-Gaudry, 2900 Edouard Montpetit Blvd, Montreal, Quebec H3T 1J4, Canada.
  • Institute of Pharmacology, West German Heart and Vascular Center, University Duisburg-Essen, Hufelandstrasse 55, Essen 45122, Germany.
  • Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Norregade 10, P.O. Box 2177, Copenhagen, Denmark.
  • Department of Thoracic and Cardiovascular Surgery, West German Heart and Vascular Center Essen, University Hospital Essen, Hufelandstrasse 55, Essen 45122, Germany.

ORCID-Profile: Arnela Saljic, Eric Thorin, Gerardo Ferbeyre, Jean-Claude Tardif, Dobromir Dobrev, Stanley Nattel

Förderung

  • CIHR
  • NHLBI NIH HHS
  • NIH HHS
  • Canadian Institutes of Health Research
  • Heart and Stroke Foundation of Canada
  • Fonds de Recherche du Québec en Santé
  • National Institutes of Health

Zitieren

APA

Mehdizadeh, M., Naud, P., Abu-Taha, I. H., Hiram, R., Xiong, F., Xiao, J., Saljic, A., Kamler, M., Vuong-Robillard, N., Thorin, E., Ferbeyre, G., Tardif, J. C., Sirois, M. G., Tanguay, J. F., Dobrev, D., & Nattel, S. (2024). The role of cellular senescence in profibrillatory atrial remodelling associated with cardiac pathology. Cardiovascular Research, 120(5), 506-518. https://doi.org/10.1093/cvr/cvae003

Vancouver

Mehdizadeh M, Naud P, Abu-Taha IH, Hiram R, Xiong F, Xiao J, et al. The role of cellular senescence in profibrillatory atrial remodelling associated with cardiac pathology. Cardiovascular Research. 2024;120(5):506-518. doi:10.1093/cvr/cvae003

BibTeX
@article{Mehdizadeh2024,
  author = {Mehdizadeh, Mozhdeh and Naud, Patrice and Abu-Taha, Issam H and Hiram, Roddy and Xiong, Feng and Xiao, Jiening and Saljic, Arnela and Kamler, Markus and Vuong-Robillard, Nhung and Thorin, Eric and Ferbeyre, Gerardo and Tardif, Jean-Claude and Sirois, Martin G and Tanguay, Jean Francois and Dobrev, Dobromir and Nattel, Stanley},
  title = {The role of cellular senescence in profibrillatory atrial remodelling associated with cardiac pathology},
  journal = {Cardiovascular Research},
  year = {2024},
  volume = {120},
  number = {5},
  pages = {506--518},
  doi = {10.1093/cvr/cvae003}
}
Kostenlos starten →